Old Web
English
Sign In
Acemap
>
authorDetail
>
Mauro Zucchetto
Mauro Zucchetto
Novartis
Pathology
Oncology
Cancer
Medicine
Internal medicine
2
Papers
23
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase 1 dose-escalation study of anti-HER3 monoclonal antibody LJM716 in combination with trastuzumab in patients with HER2-overexpressing metastatic breast or gastric cancer.
2014
Journal of Clinical Oncology
Seock-Ah Im
Dejan Juric
José Baselga
Anthony Kong
Paloma Martín
Chia-Chi Lin
Elizabeth Claire Dees
Jan H. M. Schellens
Filippo de Braud
L. Delgado
Mauro Zucchetto
Xianbin Tian
Rose Fernandez
Alex Morozov
Luc Dirix
Show All
Source
Cite
Save
Citations (10)
A phase 1 study of LJM716 in patients with esophageal squamous cell carcinoma, head and neck cancer, or HER2-overexpressing metastatic breast or gastric cancer.
2014
Journal of Clinical Oncology
Kerry Lynn Reynolds
Dejan Juric
José Baselga
Maria Alsina
Josep Tabernero
Philippe L. Bedard
Donna M. Graham
Ana M. Gonzalez-Angulo
Ignacio Garrido–Laguna
Sunil Sharma
Chia-Chi Lin
Ezra E.W. Cohen
Se-Hoon Lee
Mauro Zucchetto
Xianbin Tian
L. Delgado
Jian Li
Alex Morozov
Yung-Jue Bang
Show All
Source
Cite
Save
Citations (13)
1